CVS Health Corp. (CVS)

66.46
0.38 0.57
NYSE : Retail Trade
Prev Close 66.84
Open 67.14
Day Low/High 66.52 / 67.68
52 Wk Low/High 52.04 / 77.03
Volume 2.51M
Avg Volume 10.61M
Exchange NYSE
Shares Outstanding 1.31B
Market Cap 85.80B
EPS 5.10
P/E Ratio 11.89
Div & Yield 2.00 (3.05%)
Family Offices Inject Capital Into Budding Cannabis Industry

Family Offices Inject Capital Into Budding Cannabis Industry

Family offices, which manage billions of dollars and have much fewer restrictions on how they deploy capital, have been wading into the cannabis space with increasing frequency.

'Death by Amazon' Greatly Exaggerated

'Death by Amazon' Greatly Exaggerated

Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.

Will Rite Aid End Up Like Blockbuster?

Will Rite Aid End Up Like Blockbuster?

After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Nasdaq was the lone major index to close the day on a high note.

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Sometimes you gotta have faith, but you also have to be a little more skeptical.

Tesla Is Not Worth $420, No Matter What Musk Says: Market Recon

Tesla Is Not Worth $420, No Matter What Musk Says: Market Recon

The erratic CEO and awful fundamentals make it impossible to value TSLA -- despite attractive technicals.

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Prime Day 2018 is expected to generate $3.4 billion in sales, according to Coresight Research.

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Here's to FANG for once again exciting and enthralling and defying all of the negatives.

Here's What You Need to Know on Thursday

Here's What You Need to Know on Thursday

Let's go over the market on Thursday.

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's acquisition of PillPack is hitting traditional pharmacies.

CVS Health Has Turned the Corner to the Upside - Go Long

CVS Health Has Turned the Corner to the Upside - Go Long

More bullish signals are visible so let's do a top to bottom review of the charts and indicators.

Walgreens Presents Best Bargain in a Decade

Walgreens Presents Best Bargain in a Decade

The drugstore chain's price to fair value has not been this favorable since the Crash of 2008-2009.

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

Theranos, once a Silicon Valley unicorn promising investors and partners like Walgreens a simple blood-testing solution, is a cautionary tale for biotech investors.

Follow the Money -- Buy CVS

Follow the Money -- Buy CVS

Few companies can match CVS' long-term record and top-quality corporate metrics.

Follow the Money -- Buy CVS

Follow the Money -- Buy CVS

Insiders are buying CVS on the cheap. You should too.

We Are Never Going Back to Easy Markets: Market Recon

We Are Never Going Back to Easy Markets: Market Recon

Consistency in discipline will make the difference.

Jim Cramer: It's All About Expectations

Jim Cramer: It's All About Expectations

Earnings season is already seeing some wacky effects.

Jim Cramer: Markets Seek Domestic Tranquility

Jim Cramer: Markets Seek Domestic Tranquility

Stock markets ran higher as investors turned towards domestic-focused companies.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

CVS Health Bears Look Sated

CVS Health Bears Look Sated

A tradeable low could be in place.

Here We Are, Nine Years After the Market's Sickening Decline -- Market Recon

Here We Are, Nine Years After the Market's Sickening Decline -- Market Recon

Most of all, we have all learned that, no..... it doesn't come easy.

Bears Still Have Their Claws Into CVS Health

Bears Still Have Their Claws Into CVS Health

Keep your powder dry as CVS looks like it is still going lower.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets experienced another volatile day of trading Tuesday.

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

We have a different kind of market where you must know the SYMBOLS and know what the companies do that are the symbols.

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

The free market is going to take back control of interest rates.

CVS Health Could Continue to Surprise on the Upside

CVS Health Could Continue to Surprise on the Upside

Let's review all our charts before suggesting a strategy.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow dropped more than 300 points Tuesday.